Bringing the fundamentals into focus…
Back to Corcept Therapeutics Incorporated
How Corcept Therapeutics Incorporated stacks up
CORT · against 162 other Healthcare companies of similar size
Growth
54/ 100
Below the middle of the pack.
Ranked #93 of 163 · scores higher than 42% of peers
Bars: peers in each 10-point band of the growth score27 peers with a growth score of 50–59, including CORT · Click a bar to see the companies
Why growth scores 54?
Weighted metrics compared with all Healthcare companies.A mix: stronger 3-year revenue growth and revenue growth, but weaker earnings per share growth than most Healthcare peers.
- slower growth in earnings per share: weaker than 91% of peers. Earnings per share growth: -59.8% vs peer median 9.8%
- faster revenue growth over the last year: stronger than 73% of peers. Revenue growth: 16.0% vs peer median 6.1%
- faster revenue growth over three years: stronger than 85% of peers. 3-year revenue growth: 24.7% vs peer median 5.8%
Metric by metric
Position: dot = CORT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CORT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 163 reported | 16.0% | 10.2% | 65% | 33% | |
| Earnings per share growthHigher is better · 116 reported | -59.8% | 12.0% | 8% | 33% | |
| 3-year revenue growthHigher is better · 157 reported | 24.7% | 10.7% | 81% | 33% |
Ranking by growth score
Top 5 and the companies ranked around CORT| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 37.3B HKD (≈$4.8B) | 98 | 90 | |
| 2 | 9.3B USD | 98 | 64 | |
| 4 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 4 | 7.3B USD | 97 | 74 | |
| 91 | 47.8B HKD (≈$6.1B) | 55 | 60 | |
| 91 | 15.8B EUR (≈$17.4B) | 55 | 47 | |
| 93 | 1.09T JPY (≈$7.4B) | 54 | 75 | |
| 93 | 626.0B INR (≈$7.5B) | 54 | 68 | |
| 93 | 8.9B USD | 54 | 51 | |
| 96 | 3.6B GBP (≈$4.7B) | 53 | 64 | |
| 97 | 80.2B CNY (≈$11.2B) | 52 | 76 | |
| 97 | 64.1B CNY (≈$9.0B) | 52 | 48 | |
| 97 | 548.2B INR (≈$6.6B) | 52 | 68 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score